RT Journal
A1 NOLF PP
T1 PRoteosotherapy by the intravenous method
JF Journal of the American Medical Association
JO Journal of the American Medical Association
YR 1919
FD November 22
VO 73
IS 21
SP 1579
OP 1580
DO 10.1001/jama.1919.02610470015005
UL http://dx.doi.org/10.1001/jama.1919.02610470015005
AB The most active measures used before the war against infectious diseases can be divided into three groups: (1) vaccines; (2) serums, and (3) specific chemical substances. According, then, to the measures employed, we practiced vaccinotherapy, serotherapy or chemotherapy. In the last few years a new form of therapy has been developed which has been called proteosotherapy or proteintherapy, according as one gives a proteose as a protein foreign to the internal medium (blood and lymph) such as the casein of milk. The characteristic feature of this method is the administration of the protein or proteose by a channel which avoids the action of the digestive juices; that is to say, by a parenteral route, subcutaneous, intramuscular or intravenous. Permit me to present to you briefly my experience with proteosotherapy, which I believe I was the first to use.FIRST USE IN NONINFECTIOUS DISEASES 
    I used it first successfully in the